Sperm Count Test Market Size – By Technique (Microscopy, Chromatographic Immunoassay & Calorimetric Reaction, Smartphone-based), By Age Group (34 & Below, 34 Years, 35-40 Years, 41 Years & Above), By End-use & Forecast, 2023 - 2032

Sperm Count Test Market Size – By Technique (Microscopy, Chromatographic Immunoassay & Calorimetric Reaction, Smartphone-based), By Age Group (34 & Below, 34 Years, 35-40 Years, 41 Years & Above), By End-use & Forecast, 2023 - 2032

Sperm Count Test Market Size

Sperm Count Test Market size was valued at over USD 2 billion in 2022 and is projected to witness over 5.3% CAGR from 2023 to 2032 due to increasing awareness about male infertility across globe.
 

A sperm count test, also known as semen analysis, is a diagnostic test used to measure the quality and quantity of sperm in a man's semen. It is typically ordered by a healthcare provider to assess a man's fertility or to diagnose potential fertility problems. A sperm count test can provide important information about a man's fertility potential and may help guide treatment options for couples experiencing infertility.
 

Increasing awareness regarding fertility testing devices is a key driver of market growth. According to the World Health Organization (WHO), infertility affects approximately 15% of couples worldwide, with male factors accounting for up to 50% of cases. This has led to a growing focus on male infertility and the importance of sperm count testing in identifying the cause of infertility.
 

In addition, several healthcare organizations and advocacy groups are taking initiatives to raise awareness about male infertility and the importance of fertility testing. These efforts include campaigns to educate the public about the causes and risk factors of male infertility, and the availability and benefits of sperm count testing.
 

COVID-19 Impact

The recent outbreak of COVID-19 had a moderately negative impact on the sperm count test market. The pandemic led to disruptions in the supply chain and logistical challenges, which have impacted the availability and delivery of sperm count testing products and services. However, as the pandemic continued, there has been an increasing awareness of the potential impact of COVID-19 on male fertility, which has led to a growing demand for sperm count testing. Several studies have suggested that COVID-19 can affect male fertility by reducing sperm count and motility and improving the levels of DNA damage in sperm. This has led to an increased interest in male fertility testing and treatment, including sperm count testing.
 

Sperm Count Test Market Trends

The demand for at-home testing has been increasing in recent years, and this trend has impacted the sperm count test market. Moreover, point of care testing kits are becoming increasingly popular as they offer convenience, privacy, and ease of use. These kits allow men to collect their semen sample in the comfort of their own home, and then send the sample to a laboratory for analysis. The demand for at-home sperm count testing kits is driven by several factors, including the increasing awareness about male infertility, the need for privacy and convenience, and the high cost and inconvenience of traditional sperm count testing methods. At-home testing is also particularly appealing for men that are hesitant to visit a clinic or laboratory for testing due to social stigma or embarrassment.
 

Sperm Count Test Market Analysis

The sperm count test market is segmented by technique into microscopy, chromatographic immunoassay & calorimetric reaction, smartphone-based, and others. The microscopy segment held the largest revenue size over USD 900 million in 2022 and is estimated to witness significant growth more than USD 1,530 million by 2032. Microscopy is an essential component of sperm count testing, as it allows for the visualization and analysis of sperm cells. Microscopy provides accurate and reliable results for sperm count testing, as it allows for the direct visualization and analysis of sperm cells. Additionally, microscopy can detect abnormalities in sperm cells, such as malformed or immotile sperm, which can provide valuable information for diagnosing male infertility.
 

Sperm count test market is bifurcated based on the age group including 34 years & below, 34 years, 35-40 years, 41 years & above. The 35-40 years segment is anticipated to witness highest CAGR at 5.7% during the forecast period owing to better accuracy. The 35-40 years age group is an important demographic for the market, as male fertility tends to decline with age, and this age range represents a critical window for couples trying to conceive. Furthermore, delayed childbearing, increased awareness of male infertility, lifestyle factors, medical conditions, and availability of testing are some of the key leading factors for the 35-40 years age group in the market.
 

The sperm count test market is segmented by end-use into fertility centres, hospital & clinics, and others. Fertility centres segment dominated the global market accounting for more than 42% revenue share in 2022 and is estimated to reach USD 1 billion by 2032. Sperm count tests are an essential part of male fertility testing and are routinely performed in fertility centers to diagnose male infertility and develop appropriate treatment plans. Additionally, the incidence of male infertility is on the rise, and this has increased the demand for sperm count testing in fertility centers. Therefore, increased availability of fertility treatments, and growing healthcare infrastructure are the key hammering factors for the use of sperm count tests in fertility centers.
 

U.S. sperm count test market accounted for more than USD 785 million in 2022 and is set to surpass USD 1.23 billion by 2032. Advancements in sperm count testing technology, favourable regulatory environment, and growing healthcare expenditure are the key driving factors for the U.S. market. Further, the rise in in-vitro fertilization services owing to increasing male infertility across the U.S. is anticipated to stimulate industry statistics. The U.S. has a favourable regulatory environment for medical devices and diagnostics, including sperm count tests. This has encouraged the development and commercialization of innovative sperm count testing technologies and has also increased the availability and accessibility of these tests.
 

Sperm count test Market Share

Some of the notable key industry players operating in the sperm count test market include

• Medical Electronic Systems
• Fertility Focus Inc
• Andrology Solutions
• Vitrolife AB
• DxNow
• Hamilton Thorne
• Artron Laboratories Inc
• ExSeed Health
• Olympus Corporation Inc
• AB ANALITICA s.r.l.,
   

These market participants are implementing various growth strategies such as collaborations, partnerships, acquisitions & mergers, and new type development and launches to strengthen type offerings as well as gain a competitive edge over others.
 

Sperm count test Industry News 

• In July 2021, Hamilton Thorne announced the acquisition of Embryotech Laboratories, a leading provider of advanced embryo and sperm quality testing services. This acquisition helped company to strengthen its service offering and position in the market.
   
• In June 2021, Fertility Focus launched the new OvuSense Pro professional vaginal sensor, which provides real-time fertility monitoring for healthcare professionals.
   

Sperm count test market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments

Click here to Buy Section of this Report

By Technique (USD Million)

• Microscopy
• Chromatographic immunoassay & calorimetric reaction
• Smartphone-based
• Others

By Age Group (USD Million)

• 34 & below
• 34 years
• 35-40 years
• 41 years & above

By End-use (USD Million)

• Fertility centres
• Hospital & clinics
• Others

The above information is provided for the following regions and countries

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Russia
  • Poland
  • Switzerland
  • Norway
  • Finland
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Taiwan
  • Indonesia
  • Vietnam
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Israel